{"disease":{"id":"symptomatic-orthostatic-hypotension","name":"symptomatic orthostatic hypotension"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07196397","title":"POLish Registry of CArdioneuroablation and CArdioneuromodulation","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"SABAMED Medical Center Ltd.","has_results":false},{"nct_id":"NCT02586623","title":"Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":453,"lead_sponsor_name":"H. Lundbeck A/S","has_results":true},{"nct_id":"NCT03829657","title":"Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":203,"lead_sponsor_name":"Theravance Biopharma","has_results":true},{"nct_id":"NCT03750552","title":"Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":195,"lead_sponsor_name":"Theravance Biopharma","has_results":true},{"nct_id":"NCT04095793","title":"Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":110,"lead_sponsor_name":"Theravance Biopharma","has_results":true},{"nct_id":"NCT01515865","title":"Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"Shire","has_results":true},{"nct_id":"NCT06920134","title":"Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"Ecole Polytechnique Fédérale de Lausanne","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}